[Changes in the perioperative therapy in dental surgical procedures in patients with hemophilia and von Willebrand-Jürgens syndrome].
D000933:Antifibrinolytic Agents / Q000008:administration & dosage; D004338:Drug Combinations / Q000627:therapeutic use; D005176:Factor XIII / Q000627:therapeutic use; D015718:Fibrin Tissue Adhesive; D005340:Fibrinogen / Q000627:therapeutic use; D006467:Hemophilia A; D006801:Humans; D007430:Intraoperative Care; D009055:Mouth / Q000601:surgery; D012189:Retrospective Studies; D013917:Thrombin / Q000627:therapeutic use; D014014:Tissue Adhesives / Q000627:therapeutic use; D014070:Tooth / Q000601:surgery*; D014842:von Willebrand Diseases
D000933:Antifibrinolytic Agents; D004338:Drug Combinations; D015718:Fibrin Tissue Adhesive; D014014:Tissue Adhesives; D005340:Fibrinogen; D005176:Factor XIII; D013917:Thrombin
Zum Wandel der perioperativen Therapie zahnärztlich-chirurgischer Eingriffe bei Patienten mit Hämophilie und V.-Willebrand-Jürgens-Syndrome.